文献速递糖尿病

ENFORCE模型:2型糖尿病患者6年全因死亡风险预测

Estimation of Mortality Risk in Type 2 Diabetic Patients (ENFORCE): An Inexpensive and Parsimonious Prediction Model.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

ENFORCE是一项在意大利三个真实世界队列(GMS、FMS、PMS)及ACCORD临床试验中验证的2型糖尿病全因死亡预测模型。该模型在真实世界队列中6年死亡C统计量为0.75-0.79,汇总C统计量为0.80;在ACCORD试验中C统计量为0.68,显著低于真实世界样本(P<0.0001)。ENFORCE是免费且易用的真实世界白人2型糖尿病患者全因死亡风险计算器。

要点

  • ENFORCE模型可预测真实世界白人2型糖尿病患者6年全因死亡风险。
  • 真实世界队列中6年死亡C统计量0.75-0.79,汇总0.80。
  • 临床试验设置下C统计量0.68,显著低于真实世界样本(P<0.0001)。

核心结论

  • ENFORCE模型的时间范围已扩展至6年,并在三个独立样本中得到验证。
  • ENFORCE是免费且易用的真实世界白人2型糖尿病患者全因死亡风险计算器。

研究设计与样本

  • 观察性前瞻性随机临床试验。
  • 真实世界样本:Gargano死亡研究(GMS,n=1019)、Foggia死亡研究(FMS,n=1045)和Pisa死亡研究(PMS,n=972)。
  • 临床试验样本:ACCORD试验标准降糖组(n=3150)。
  • 研究对象为白人2型糖尿病患者,终点为全因死亡。

主要发现

  • ENFORCE在GMS、FMS和PMS中的6年死亡C统计量分别为0.79、0.78和0.75(异质性P=0.71)。
  • 汇总三个队列的6年死亡C统计量为0.80。
  • 在ACCORD试验中,ENFORCE的C统计量为0.68,显著低于汇总真实世界样本(P<0.0001)。

临床怎么用

  • ENFORCE可免费使用,用于真实世界白人2型糖尿病患者6年全因死亡风险评估。
  • 在临床试验设置中应用时需注意其区分度可能低于真实世界场景。

局限性

  • 研究仅纳入白人2型糖尿病患者。
  • 临床试验设置下模型区分度显著低于真实世界样本。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: We previously developed and validated an inexpensive and parsimonious prediction model of 2-year all-cause mortality in real-life patients with type 2 diabetes. OBJECTIVE: This model, now named ENFORCE (EstimatioN oF mORtality risk in type 2 diabetiC patiEnts), was investigated in terms of (i) prediction performance at 6 years, a more clinically useful time-horizon; (ii) further validation in an independent sample; and (iii) performance comparison in a real-life vs a clinical trial setting. DESIGN: Observational prospective randomized clinical trial. SETTING: White patients with type 2 diabetes. PATIENTS: Gargano Mortality Study (GMS; n = 1019), Foggia Mortality Study (FMS; n = 1045), and Pisa Mortality Study (PMS; n = 972) as real-life samples and the standard glycemic arm of the ACCORD (Action to Control Cardiovascular Risk in Diabetes) clinical trial (n = 3150). MAIN OUTCOME MEASURE: The endpoint was all-cause mortality. Prediction accuracy and calibration were estimated to assess the model's performances. RESULTS: ENFORCE yielded 6-year mortality C-statistics of 0.79, 0.78, and 0.75 in GMS, FMS, and PMS, respectively (P heterogeneity = 0.71). Pooling the three cohorts showed a 6-year mortality C-statistic of 0.80. In the ACCORD trial, ENFORCE achieved a C-statistic of 0.68, a value significantly lower than that obtained in the pooled real-life samples (P < 0.0001). This difference resembles that observed with other models comparing real-life vs clinical trial settings, thus suggesting it is a true, replicable phenomenon. CONCLUSIONS: The time horizon of ENFORCE has been extended to 6 years and validated in three independent samples. ENFORCE is a free and user-friendly risk calculator of all-cause mortality in white patients with type 2 diabetes from a real-life setting.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Copetti M, Shah H, Fontana A, et al. Estimation of Mortality Risk in Type 2 Diabetic Patients (ENFORCE): An Inexpensive and Parsimonious Prediction Model. J Clin Endocrinol Metab. 2019. PMID: 31087060. doi:10.1210/jc.2019-00215

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。